Schiff Nutrition International, Inc. (formerly Weider Nutrition
International, Inc.), (NYSE:WNI), today announced results for the
fiscal 2006 second quarter and six months ended November 30, 2005.
Schiff Nutrition's net sales were $35.5 million for the second
quarter, compared to $44.3 million for the same period in fiscal
2005. For its fiscal 2006 second quarter, Schiff Nutrition reported
net income of $1.5 million, or $0.06 per share, compared to $3.5
million, or $0.13 per share, for the same period a year ago. Schiff
Nutrition's net sales were $83.5 million for the six months ended
November 30, 2005, compared to $88.0 million for the same period in
fiscal 2005. For the first six months of fiscal 2006, Schiff
Nutrition reported net income of $6.5 million, or $0.24 per share,
compared to $7.2 million, or $0.27 per share, for the same period a
year ago. Bruce Wood, president and chief executive officer,
stated, "Second quarter sales declined as expected, primarily due
to the discontinuance of certain private label business. Our
branded sales also declined slightly in the quarter, but they are
up approximately 8 percent for the first six months. Moreover, we
are encouraged by the current overall strong performance in our
branded sales at the retail level, as measured by Information
Resources, Inc. and customer point of sale data." Wood continued,
"We expect to build our branded sales with the fiscal third quarter
introduction of new Move Free(R) Advanced Formula. Based on
clinical research, we believe Move Free Advanced is superior to
typical glucosamine chondroitin combination products, which have
already been proven effective in promoting joint health. We will be
providing substantial marketing support for this proprietary new
product, beginning in our fiscal third quarter. "Our positive
fiscal year to date branded sales results, coupled with the
introduction of Move Free Advanced, give us reason to believe that
our continued strategic focus on profitable branded growth will
positively impact fiscal 2007 and beyond." Conference Call
Information Schiff Nutrition International will hold a conference
call today, January 12 at 11 a.m. ET. The U.S. domestic access
number is 800-591-6930. International participants should dial
617-614-4908. Please call in approximately ten minutes in advance.
The conference call will be broadcast live over the Internet at
www.schiffnutrition.com. A replay of the call will be available by
dialing 888-286-8010 for domestic callers and 617-801-6888 for
international callers; enter access code 96835623. The telephone
replay will be available through January 17, 2006. About Schiff
Nutrition Schiff Nutrition International, Inc. (formerly Weider
Nutrition International, Inc.) develops, manufactures, markets and
sells branded and private label vitamins, nutritional supplements
and nutrition bars in the United States and throughout the world.
To learn more about Schiff, please visit the web site
www.schiffnutrition.com. This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and section 21E of the
Securities Exchange Act of 1934, as amended, that are based on
management's beliefs and assumptions, current expectations,
estimates, and projections. These statements are subject to risks
and uncertainties, certain of which are beyond the company's
ability to control or predict, and, therefore, actual results may
differ materially. Schiff Nutrition disclaims any obligation to
update any forward-looking statements whether as a result of new
information, future events or otherwise. Important factors that may
cause these forward-looking statements to be false include, but are
not limited to: the ability to successfully launch Move Free
Advanced, the inability to successfully implement marketing and
spending programs behind our Move Free brand and other new branded
products, the impact of raw material pricing and availability
(particularly relating to joint care products), the mix between
branded and private label products and our ability to grow branded
sales, the inability to achieve cost savings and operational
efficiencies, the inability to increase operating margins and
increase revenues, dependence on individual products, dependence on
individual customers, the impact of competitive products and
pricing (including private label), market and industry conditions
(including pricing, demand for products and level of trade
inventories), the impact of clinical studies regarding nutritional
supplements, particularly relating to the joint care category, the
success of product development, the inability to obtain customer
acceptance of new product introductions, changes in laws and
regulations, litigation and government regulatory action,
uncertainty of market acceptance of new products, adverse publicity
regarding the consumption of nutritional supplements, the inability
to find strategic acquisitions or the inability to successfully
consummate or integrate an acquisition, changes in accounting
standards, and other factors indicated from time to time in the
company's SEC reports, copies of which are available upon request
from the company's investor relations department or may be obtained
at the SEC's web site (www.sec.gov). -0- *T SCHIFF NUTRITION
INTERNATIONAL, INC. CONSOLIDATED CONDENSED STATEMENTS OF INCOME (IN
THOUSANDS, EXCEPT PER SHARE AMOUNTS) (unaudited) Three Months Ended
Six Months Ended November 30, November 30, -------------------
------------------- 2005 2004 2005 2004 --------- ---------
--------- --------- Net sales $ 35,456 $ 44,268 $ 83,473 $ 87,963
Cost of goods sold 24,246 28,225 59,554 55,117 --------- ---------
--------- --------- Gross profit 11,210 16,043 23,919 32,846
--------- --------- --------- --------- Operating expenses: Selling
and marketing 6,060 6,142 12,076 13,357 Other operating expenses
3,761 4,286 6,677 8,919 --------- --------- --------- ---------
Total operating expenses 9,821 10,428 18,753 22,276 ---------
--------- --------- --------- Income from operations 1,389 5,615
5,166 10,570 Other income (expense), net 305 (16) 2,254 (186)
--------- --------- --------- --------- Income from continuing
operations before income taxes 1,694 5,599 7,420 10,384 Income
taxes 89 2,155 823 3,997 --------- --------- --------- ---------
Income from continuing operations 1,605 3,444 6,597 6,387 Income
(loss) from discontinued operations, net of tax (70) 20 (127) 765
--------- --------- --------- --------- Net income $ 1,535 $ 3,464
$ 6,470 $ 7,152 ========= ========= ========= ========= Weighted
average common shares outstanding -- diluted 26,866 26,487 26,820
26,525 ========= ========= ========= ========= Net income per share
-- diluted: Income from continuing operations $ 0.06 $ 0.13 $ 0.25
$ 0.24 Income (loss) from discontinued operations - - (0.01) 0.03
--------- --------- --------- --------- Net income $ 0.06 $ 0.13 $
0.24 $ 0.27 ========= ========= ========= ========= SCHIFF
NUTRITION INTERNATIONAL, INC. CONSOLIDATED CONDENSED BALANCE SHEETS
(IN THOUSANDS) November 30, 2005 May 31, 2005 -----------------
----------------- (unaudited) Cash and cash equivalents $ 24,275 $
11,358 Investment securities 29,075 24,212 Receivables, net 15,382
29,300 Inventories 24,686 32,419 Other current assets 6,468 7,154
----------------- ----------------- Total current assets 99,886
104,443 ----------------- ----------------- Property and equipment,
net 13,058 16,714 Other assets, net 4,673 7,109 -----------------
----------------- 17,731 23,823 ----------------- -----------------
Total assets $ 117,617 $ 128,266 =================
================= Short-term debt $ 974 $ 3,020 Other current
liabilities 19,300 35,411 ----------------- ----------------- Total
current liabilities 20,274 38,431 Deferred taxes 673 -
Stockholders' equity 96,670 89,835 -----------------
----------------- Total liabilities & stockholders' equity $
117,617 $ 128,266 ================= ================= *T
Schiff Nutrit (NYSE:WNI)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 6์(6) 2024 ์ผ๋ก 7์(7) 2024
Schiff Nutrit (NYSE:WNI)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 7์(7) 2023 ์ผ๋ก 7์(7) 2024